Dual role of the peptide-loading complex as proofreader and limiter of MHC-I presentation
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2321600121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Jamina Brunnberg und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry, Biocenter, Goethe University Frankfurt, Frankfurt am Main 60438, Germany. Hauptthemen laut MEDLINE: Antigen Presentation, Peptides, Histocompatibility Antigens Class I. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG), EC | ERC | HORIZON EUROPE European Research Council (ERC).
Abstract (Originalsprache)
Antigen presentation via major histocompatibility complex class I (MHC-I) molecules is essential for surveillance by the adaptive immune system. Central to this process is the peptide-loading complex (PLC), which translocates peptides from the cytosol to the endoplasmic reticulum and catalyzes peptide loading and proofreading of peptide-MHC-I (pMHC-I) complexes. Despite its importance, the impact of individual PLC components on the presented pMHC-I complexes is still insufficiently understood. Here, we used stoichiometrically defined antibody–nanobody complexes and engineered soluble T cell receptors (sTCRs) to quantify different MHC-I allomorphs and defined pMHC-I complexes, respectively. Thereby, we uncovered distinct effects of individual PLC components on the pMHC-I surface pool. Knockouts of components of the PLC editing modules, namely tapasin, ERp57, or calreticulin, changed the MHC-I surface composition to a reduced proportion of HLA-A*02:01 presentation compensated by a higher ratio of HLA-B*40:01 molecules. Intriguingly, these knockouts not only increased the presentation of suboptimally loaded HLA-A*02:01 complexes but also elevated the presentation of high-affinity peptides overexpressed in the cytosol. Our findings suggest that the components of the PLC editing module serve a dual role, acting not only as peptide proofreaders but also as limiters for abundant peptides. This dual function ensures the presentation of a broad spectrum of antigenic peptides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biochemistry, Biocenter, Goethe University Frankfurt, Frankfurt am Main 60438, Germany.
- Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna 1090, Austria.
- Immunocore Ltd., Abingdon OX14 4RY, United Kingdom.
ORCID-Profile: Stefan Frühschulz, Claire Battin, Ben de Wet, Peter Steinberger, Robert Tampé
Förderung
- Deutsche Forschungsgemeinschaft (DFG)
- EC | ERC | HORIZON EUROPE European Research Council (ERC)
Zitieren
APA
Brunnberg, J., Barends, M., Frühschulz, S., Winter, C., Battin, C., de Wet, B., Cole, D. K., Steinberger, P., & Tampé, R. (2024). Dual role of the peptide-loading complex as proofreader and limiter of MHC-I presentation. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2321600121
Vancouver
Brunnberg J, Barends M, Frühschulz S, Winter C, Battin C, de Wet B, et al. Dual role of the peptide-loading complex as proofreader and limiter of MHC-I presentation. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2321600121
BibTeX
@article{Brunnberg2024,
author = {Brunnberg, Jamina and Barends, Martina and Frühschulz, Stefan and Winter, Christian and Battin, Claire and de Wet, Ben and Cole, David K and Steinberger, Peter and Tampé, Robert},
title = {Dual role of the peptide-loading complex as proofreader and limiter of MHC-I presentation},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2321600121}
}
EUVIMED